• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

FRET/ BRET analysis of interaction between HCV protein and interferon signaling

Research Project

Project/Area Number 21590831
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Gastroenterology
Research InstitutionTokyo Medical and Dental University

Principal Investigator

FUJITA Megumi (TASAKA Megumi)  東京医科歯科大学, 大学院・医歯学総合研究科, 特任助教 (50510369)

Co-Investigator(Kenkyū-buntansha) ASAHINA Yasuhiro  東京医科歯科大学, 大学院・医歯学総合研究科, 教授 (00422692)
AZUMA Seishin  東京医科歯科大学, 医学部附属病院, 講師 (10376783)
SAKAMOTO Naoya  北海道大学, 医学系研究科, 教授 (10334418)
Project Period (FY) 2009 – 2012
Project Status Completed (Fiscal Year 2012)
Budget Amount *help
¥5,720,000 (Direct Cost: ¥4,400,000、Indirect Cost: ¥1,320,000)
Fiscal Year 2012: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2011: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2010: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2009: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
KeywordsHCV レプリコン / インターフェロン / RIG-I / HCV-NS4B / STING / HCVレプリコン / Cardif / 生体発光共鳴エネルギー転移(Bioliminescence Resonance Energy ransfer)
Research Abstract

We investigated protein interaction between Hepatitis C virus (HCV)-NS4B and signaling molecules associated with interferon (IFN) production, including Cardif, and STING. The weak interaction between HCV-NS4B and Cardif was observed. Our data, including BiFC analysis, immunoprecipitation assay, and immunostaining, demonstrated that HCV-NS4B specifically bindsSTING. We showed that NS4B suppresses STING-mediated IFN production.

Report

(4 results)
  • 2012 Annual Research Report   Final Research Report ( PDF )
  • 2011 Annual Research Report
  • 2009 Annual Research Report
  • Research Products

    (86 results)

All 2013 2012 2011 2009 Other

All Journal Article (37 results) (of which Peer Reviewed: 36 results,  Open Access: 1 results) Presentation (44 results) (of which Invited: 1 results) Book (4 results) Patent(Industrial Property Rights) (1 results)

  • [Journal Article] Hepatitis C virus NS4B protein targets STING and abrogates RIG-I-mediated type-I interferon-dependent innate immunity2013

    • Author(s)
      Nitta S, Sakamoto N, Nakagawa M, Kakinuma S, Mishima K, Kusano-kitazume A, Kiyohashi K, Murakawa M, Nishimura-Sakurai Y, Azuma S, Tasaka-Fujita M, asahina Y, Yoneyama M, Fujita T, Watanabe M
    • Journal Title

      Hepatology

      Volume: 57 Issue: 1 Pages: 46-58

    • DOI

      10.1002/hep.26017

    • Related Report
      2012 Annual Research Report 2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] Wnt5a Signaling Mediates Biliary Differentiation of Fetal Hepatic Stem/Progenitor Cells2013

    • Author(s)
      Kakinuma S, Kiyohashi K, Kamiya A, Sakamoto N, Nitta S, Yamanaka H, YoshinoK, Fujiki J, Murakawa M, Kusano-Kitazume A, Shimizu H, Okamoto R, Azuma S, Nakagawa M, Asahina Y, Tanimizu N, Kikuchi A, Nakauchi H, and *WatanabeM
    • Journal Title

      Hepatology

      Volume: (in press) Issue: 6 Pages: 2502-2513

    • DOI

      10.1002/hep.26293

    • Related Report
      2012 Annual Research Report 2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] α-fetoprotein levels afterinterferon therapy and risk of hepatocarcinogenesis in chronic hepatitis C2013

    • Author(s)
      Asahina Y, Tsuchiya K, Nishimura T, Muraoka M, Suzuki Y, Tamaki N, Yasui Y, Hosokawa T, Ueda K, Nakanishi H, Itakura J, Takahashi Y, Kurosaki M, Enomoto N, Nakagawa M, Kakinuma S, Watanabe M,Izumi N
    • Journal Title

      Hepatology

      Volume: (in press) Issue: 4 Pages: 1253-1262

    • DOI

      10.1002/hep.26442

    • Related Report
      2012 Annual Research Report 2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] Inhibition of hepatocellular carcinoma by PegIFNα2a in patients with chronic hepatitis C: a nationwide multi-center cooperative study.2013

    • Author(s)
      Izumi N, Asahina Y, Kumada H et al
    • Journal Title

      J Gastroenterol

      Volume: 48 Issue: 3 Pages: 382-390

    • DOI

      10.1007/s00535-012-0641-9

    • Related Report
      2012 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Noninvasive estimation of fibrosis progression overtime using the FIB-4 index in chronic hepatitis C.2013

    • Author(s)
      Tamaki N, Asahina Y, Izumi N et al
    • Journal Title

      J Viral Hepat

      Volume: 20 Issue: 1 Pages: 72-76

    • DOI

      10.1111/j.1365-2893.2012.01635.x

    • Related Report
      2012 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Model incorporating the ITPA genotype identifies patients at high risk of anemia and treatment failure with pegylated-interferon plus ribavirin therapy for chronic hepatitis C.2013

    • Author(s)
      Kurosaki M, Sakamoto N, Asahina Y, Izumi N et al
    • Journal Title

      J Med Virol

      Volume: 85 Issue: 3 Pages: 449-458

    • DOI

      10.1002/jmv.23497

    • Related Report
      2012 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Virological response and safety of 24-week telaprevir alone in Japanese patients infected with hepatitis C virus subtype 1b.2013

    • Author(s)
      Toyota J, Asahina Y, Kumada H et al
    • Journal Title

      J Viral Hepat

      Volume: 20 Issue: 3 Pages: 167-173

    • DOI

      10.1111/j.1365-2893.2012.01640.x

    • Related Report
      2012 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Impaired brain activity in cirrhotic patients with minimal hepatic encephalopathy: evaluation by near infrared spectroscopy.2013

    • Author(s)
      Nakanishi H,Asahina Y, Izumi N et al
    • Journal Title

      Hepatol Res

      Volume: in press Issue: 3 Pages: 319-326

    • DOI

      10.1111/hepr.12127

    • Related Report
      2012 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Guidelines for the Management of Hepatitis C Virus Infection.2013

    • Author(s)
      Asahina Y, Hayashi N, Yotsuyanagi H et al
    • Journal Title

      Hepatology Research

      Volume: 43 Pages: 1-34

    • NAID

      130003384472

    • Related Report
      2012 Annual Research Report
  • [Journal Article] Identification of novel N-(morpholine-4-carbonyloxy) amidine compounds as potent inhibitors against hepatitis C virus replication2012

    • Author(s)
      Kusano-Kitazume A, Sakamoto N, Okuno Y, Sekine-Osajima Y, Nakagawa M, Kakinuma S, Kiyonashi K, Nitta S, Murakawa M, Azuma S, Nishimura-Sakurai Y, Hagiwara M, Watanabe M
    • Journal Title

      Antimicrob Agent Chemother

      Volume: 56(3) Issue: 3 Pages: 1315-23

    • DOI

      10.1128/aac.05764-11

    • Related Report
      2012 Final Research Report 2011 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Genome-wide association study confirming association of HLA-DP with protection against chronic hepatitis B and viral clearance in Japanese and Korean.2012

    • Author(s)
      Nishida N, Asahina Y, Mizokami M et al
    • Journal Title

      PLoS One

      Volume: 7 Issue: 6 Pages: 1-8

    • DOI

      10.1371/journal.pone.0039175

    • Related Report
      2012 Annual Research Report
    • Peer Reviewed
  • [Journal Article] No association for Chinese HBV-related hepatocellular carcinoma susceptibility SNP in other East Asian populations.2012

    • Author(s)
      Sawai H, Asahina Y, Tokunaga K et al
    • Journal Title

      BMC Med Genet

      Volume: 13 Issue: 1 Pages: 47-47

    • DOI

      10.1186/1471-2350-13-47

    • Related Report
      2012 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Inhibition of hepatitis C virus NS5B polymerase by S-trityl-L-cysteine derivatives2012

    • Author(s)
      Kaushik-Basu N, Sakamoto N
    • Journal Title

      Eur J Med Chem

      Volume: 49 Pages: 191-199

    • DOI

      10.1016/j.ejmech.2012.01.010

    • Related Report
      2011 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Age and total ribavirin dose are independent predictors of relapse after interferon therapy in chronic hepatitis C revealed by data mining analysis2012

    • Author(s)
      Kurosaki M, Sakamoto N, et al
    • Journal Title

      Antivir Ther

      Volume: 17(1) Pages: 35-43

    • Related Report
      2011 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Data mining model using simple and readily available factors could identify patients at high risk for hepatocellular carcinoma in chronic hepatitis C2012

    • Author(s)
      Kurosaki M, Sakamoto N, Nakagawa M, et al.
    • Journal Title

      J Hepatol

      Volume: 56(3) Issue: 3 Pages: 602-608

    • DOI

      10.1016/j.jhep.2011.09.011

    • Related Report
      2011 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Analysis of interferon signaling by infectious hepatitis C virus clones with substitutions of core amino acids 70 and 912011

    • Author(s)
      Funaoka Y, Sakamoto N, Suda G, Itsui Y, Nakagawa M, Kakinuma S, Watanabe T, Nitta S, Kitazume A, Kiyohashi K, Murakawa M, Azuma S, Tsuchiya K,Watanabe M
    • Journal Title

      J Virol

      Volume: 85 Issue: 12 Pages: 5986-94

    • DOI

      10.1128/jvi.02583-10

    • Related Report
      2012 Final Research Report 2011 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Inhibitory effect of a triterpenoid compound, with or without alpha interferon, on hepatitis C virus infection2011

    • Author(s)
      Watanabe T, Sakamoto N, Nakagawa M, Azuma S, Watanabe M, et al.
    • Journal Title

      Antimicrob Agents Chemother

      Volume: 55(6) Issue: 6 Pages: 2537-2545

    • DOI

      10.1128/aac.01780-10

    • Related Report
      2012 Final Research Report 2011 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Serum interleukin-6 levels correlate with resistance to treatment of chronic hepatitis C infection withpegylated-interferon-α2b plus ribavirin2011

    • Author(s)
      Ueyama M, Nakagawa M, Sakamoto N,Onozuka I, Funaoka Y, Watanabe T, Nitta S, Kiyohashi K, Kitazume A, Murakawa M, Nishimura-Sakurai Y, Sekine-Osajima Y, Itsui Y, Azuma S, Kakinuma S, Watanabe M and the Ochanomizu-Liver Conference Study Group
    • Journal Title

      Antivir Ther

      Volume: 16 Issue: 7 Pages: 1081-1091

    • DOI

      10.3851/imp1864

    • Related Report
      2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] Studies on virus kinetics using infectious fluorescence-tagged hepatitis C virus cell culture2011

    • Author(s)
      Yamamoto M, Sakamoto N, Nakamura T, Itsui Y, Nakagawa M, Nishimura-Sakurai Y, Kakinuma S, Azuma S, Kato T, Wakita T, Watanabe M
    • Journal Title

      Hepatol Res

      Volume: 41 Issue: 3 Pages: 258-269

    • DOI

      10.1111/j.1872-034x.2010.00771.x

    • Related Report
      2012 Final Research Report 2011 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Association of IL28B variants with response to pegylated-interferon alpha plus ribavirin combination therapy reveals intersubgenotypic differences between genotypes 2a and 2b2011

    • Author(s)
      Sakamoto N, Nakagawa M, Azuma S, Watanabe M, et al.
    • Journal Title

      J Med Virol

      Volume: 83 Issue: 5 Pages: 871-878

    • DOI

      10.1002/jmv.22038

    • Related Report
      2012 Final Research Report 2011 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Association of gene expression involving innate immunity and genetic variation in IL28B with antiviral response2011

    • Author(s)
      Asahina Y, Sakamoto N, et al
    • Journal Title

      Hepatology

      Volume: 55(1) Issue: 1 Pages: 20-29

    • DOI

      10.1002/hep.24623

    • Related Report
      2012 Annual Research Report 2011 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Analysis of the complete open reading frame of hepatitis C virus in genotype 2a infection reveals critical sites influencing the response to peginterferon and ribavirin therapy2011

    • Author(s)
      Kadokura M, Nakagawa M, Sakamoto N, Watanabe M, et al.
    • Journal Title

      Hepatol Int

      Volume: 5(3) Issue: 3 Pages: 789-799

    • DOI

      10.1007/s12072-011-9267-x

    • Related Report
      2011 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Use of human hepatocyte-like cells derived from induced pluripotent stem cells as a model for hepatocytes in hepatitis C virus infection2011

    • Author(s)
      Yoshida T, Sakamoto N, et al
    • Journal Title

      Biochem Biophys Res Commun

      Volume: 416(1-2) Issue: 1-2 Pages: 119-124

    • DOI

      10.1016/j.bbrc.2011.11.007

    • Related Report
      2011 Annual Research Report
    • Peer Reviewed
  • [Journal Article] A new method for induced fit docking (GENIUS) and its application to virtual screening of novel HCV NS3-4A protease inhibitors2011

    • Author(s)
      Takaya D, Sakamoto N, et al.
    • Journal Title

      Bioorganic & Medicinal Chemistry

      Volume: 19(22) Issue: 22 Pages: 6892-6905

    • DOI

      10.1016/j.bmc.2011.09.023

    • Related Report
      2011 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Serum interleukin-6 levels correlate with resistance to treatment of chronic hepatitis C infection with pegylated-interferon-alpha2b plus ribavirin2011

    • Author(s)
      Ueyama M, Sakamoto N, et al
    • Journal Title

      Antivir Ther

      Volume: 16 Pages: 1081-1091

    • Related Report
      2011 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Genome-wide association study identified ITPA/DDRGK1 variants reflecting thrombocytopenia in pegylated interferon and ribavirin therapy for chronic hepatitis C2011

    • Author(s)
      Tanaka Y, Sakamoto N, et al.
    • Journal Title

      Human Molecular Genetics

      Volume: 20(17) Issue: 17 Pages: 3507-3516

    • DOI

      10.1093/hmg/ddr249

    • Related Report
      2011 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Pretreatment Prediction of Anemia Progression by Peginterferon Plus Ribavirin Therapy in Chronic Hepatitis C : Decision-Tree Analysis2011

    • Author(s)
      Hiramatsu N, Sakamoto N, et al.
    • Journal Title

      J Gastroenterol

      Volume: 46(9) Issue: 9 Pages: 1111-1119

    • DOI

      10.1007/s00535-011-0412-z

    • Related Report
      2011 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Analysis of the complete open reading frame of genotype 2b hepatitis C virus in association with the response to peginterferon and ribavirin therapy2011

    • Author(s)
      Kadokura M, Nakagawa M, Sakamoto N, Watanabe M, et al.
    • Journal Title

      PLoS One

      Volume: 6(9) Issue: 9 Pages: e24514-e24514

    • DOI

      10.1371/journal.pone.0024514

    • Related Report
      2011 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Pretreatment prediction of response to peginterferon plus ribavirin therapy in genotype 1 chronic hepatitis C using data mining analysis2011

    • Author(s)
      Kurosaki M, Sakamoto N, et al.
    • Journal Title

      J Gastroenterol

      Volume: 46(3) Issue: 3 Pages: 401-409

    • DOI

      10.1007/s00535-010-0322-5

    • NAID

      10029028096

    • Related Report
      2011 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Adenovirus vector-mediated assay system for hepatitis C virus replication2011

    • Author(s)
      Yoshida T, Sakamoto N, et al
    • Journal Title

      Nucleic Acids Res

      Volume: 39(10) Issue: 10 Pages: e64-e64

    • DOI

      10.1093/nar/gkr047

    • Related Report
      2011 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Association between lipid accumulation and the cannabinoid system in Huh7 cells expressing HCV genes2011

    • Author(s)
      Toyoda M, Sakamoto N, et al
    • Journal Title

      Int J Mol Med

      Volume: 27 Issue: 5 Pages: 619-624

    • DOI

      10.3892/ijmm.2011.622

    • Related Report
      2011 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Cholestatic liver fibrosis and toxin-induced fibrosis are exacerbated in matrix metalloproteinase-2 deficient mice2011

    • Author(s)
      Onozuka I, Sakamoto N, Nakagawa M, Watanabe M, et al.
    • Journal Title

      Biochem Biophys Res Commun

      Volume: 406 Issue: 1 Pages: 134-140

    • DOI

      10.1016/j.bbrc.2011.02.012

    • Related Report
      2011 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Pre-treatment prediction of response to pegylated-interferon plus ribavirin for chronic hepatitis C using genetic polymorphism in IL28B and viral factors2011

    • Author(s)
      Kurosaki M, Sakamoto N, Nakagawa M, Watanabe M, et al.
    • Journal Title

      J Hepatol

      Volume: 54 Issue: 3 Pages: 439-448

    • DOI

      10.1016/j.jhep.2010.07.037

    • Related Report
      2011 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Sequences in the interferon sensitivity-determining region and core region of hepatitis C virus impact pretreatment prediction of response to PEG-interferon plus ribavirin : data mining analysis2011

    • Author(s)
      Kurosaki M, Sakamoto N, Nakagawa M, et al.
    • Journal Title

      J Med Virol

      Volume: 83 Issue: 3 Pages: 445-452

    • DOI

      10.1002/jmv.22005

    • Related Report
      2011 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Antiviral effects of the interferon-induced protein guanylate binding protein 1 and its interaction with the hepatitis C virus NS5Bprotein2009

    • Author(s)
      Itsui Y, Sakamoto N, Kakinuma S, Nakagawa M, Sekine-Osajima Y, Tasaka-Fujita M, Nishimura-Sakurai Y, Suda G, Karakama Y, Mishima K, Yamamoto M, Watanabe T, Ueyama M, Funaoka Y, Azuma S, Watanabe M
    • Journal Title

      Hepatology

      Volume: 50(6) Issue: 6 Pages: 1727-37

    • DOI

      10.1002/hep.23195

    • Related Report
      2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] HCV-associated gene expression and cell signaling pathway in cells with or without HCV replicon and in replicon-cured cells.2009

    • Author(s)
      Nishimura-Sakurai Y, Sakamoto N, Megumi Tasaka-Fujita
    • Journal Title

      J.Gastroentelorogy

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Antiviral effects of the interferon-induced protein GBP-1 and its interaction with the hepatitis C virus NS5B protein2009

    • Author(s)
      Itsui Y, Sakamoto N, Megumi Tasaka- Fujita
    • Journal Title

      Hepatology 50

      Pages: 1727-1737

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Presentation] Serum interleukin-6 levels during treatment correlate with resistance to telaprevir-based triple therapy in chronic hepatitis C.2013

    • Author(s)
      Asahina Y
    • Organizer
      EASL: The international liver congress 2013
    • Place of Presentation
      Amsterdam
    • Related Report
      2012 Annual Research Report
  • [Presentation] HCVgenotype 1b株キメラウイルスを用いた HCV core領域アミノ酸70/91変異株の解析2012

    • Author(s)
      藤田めぐみ 、脇田隆字、加藤孝宣
    • Organizer
      第48回日本肝臓学会総会
    • Place of Presentation
      金沢
    • Year and Date
      2012-06-08
    • Related Report
      2012 Final Research Report
  • [Presentation] HCV-NS4B protein binds STINGand blocks the RIG-I mediated IFN pathway2012

    • Author(s)
      Sayuri Nitta, Naoya Sakamoto, Mina Nakagawa, Sei Kakinuma, Akiko Kusano Kitazume, Miyako Murakawa, Megumi Tasaka-Fujita, Yasuhiro Asahina, Mamoru Watanabe
    • Organizer
      10th single topic conference
    • Place of Presentation
      Tokyo
    • Related Report
      2012 Final Research Report
  • [Presentation] HCV-NS4B blocks the RIG-I mediated IFN pathway through targeting of STING2012

    • Author(s)
      Sayuri Nitta, Naoya Sakamoto, Mina Nakagawa, Sei Kakinuma, Kako Mishima, Akiko Kusano-Kitazume, Kei Kiyohashi, Miyako Murakawa, Kohei Yoshino, Megumi Tasaka-Fujita, Yasuhiro Asahina, Mamoru Watanabe
    • Organizer
      19^<th> International Symposium of Hepatitis C Virus and Related Viruses
    • Place of Presentation
      Venice, Italy
    • Related Report
      2012 Final Research Report
  • [Presentation] HCV NS4B蛋白によるRIG-I誘導性Interferon発現経路の抑制機構についての解析2012

    • Author(s)
      新田沙由梨、 坂本直哉 、吉野耕平、村川美也子、北詰晶子、幾世橋佳、東正新、柿沼晴、中川美奈、朝比奈靖浩、渡辺守
    • Organizer
      JDDW2012
    • Place of Presentation
      神戸
    • Related Report
      2012 Final Research Report
  • [Presentation] IFN不応例における宿主自然免疫応答とHCV逃避機構2012

    • Author(s)
      新田沙由梨,朝比奈靖浩,坂本直哉,村川美也子,北詰晶子,幾世橋佳,東正新,柿沼晴,中川美奈,渡辺守
    • Organizer
      第77回日本インターフェロン・サイトカイン学会
    • Place of Presentation
      神戸
    • Related Report
      2012 Final Research Report
  • [Presentation] HCVNS4B蛋白はSTINGを介しRIG-I誘導性 Interferon産生応答を抑制する2012

    • Author(s)
      新田沙由梨、 坂本直哉、吉野耕平、村川美也子、北詰晶子、幾世橋佳、東正新、柿沼晴、中川美奈、 朝比奈靖浩、渡辺守
    • Organizer
      第48回肝臓学会総会
    • Place of Presentation
      金沢
    • Related Report
      2012 Final Research Report
  • [Presentation] Supression of Alpha-fetoprotein by Interferon Therapy Reduces The Risk of Hepatocarcinogenesis in Patients with Chronic Hepatitis C.2012

    • Author(s)
      Asahina Y,Tsuchiya K, Izumi N et al
    • Organizer
      EASL: The international liver congress 2012
    • Place of Presentation
      Barcelona
    • Related Report
      2012 Annual Research Report
  • [Presentation] Risk factors for exceeding the Milan criteria following successful radiofrequency ablation in patients with early stage hepatocellular carcinoma: determination of patients requiring early transplantation or new adjuvant therapy.2012

    • Author(s)
      Tsuchiya K, Asahina Y, Izumi N et al
    • Organizer
      AASLD The Liver Meeting 2012
    • Place of Presentation
      Boston
    • Related Report
      2012 Annual Research Report
  • [Presentation] Reduced organic anion transporter 2 expression is associated with a high risk for hepatocellulare carcinoma in chronic hepatitis C patients: a propensity score-matched study.2012

    • Author(s)
      Yasui Y, Asahina Y, Izumi N et al
    • Organizer
      AASLD The Liver Meeting 2012
    • Place of Presentation
      Boston
    • Related Report
      2012 Annual Research Report
  • [Presentation] Imparied IL28B gene induction and poor IL28B promoter activity influenced by the IL28B minor allele are closely associated with a null response to interferon in chronic hepatitis C patients.2012

    • Author(s)
      Asahina Y, Sakamoto N, Azuma S, Watanabe M et al
    • Organizer
      AASLD The Liver Meeting 2012
    • Place of Presentation
      Boston
    • Related Report
      2012 Annual Research Report
  • [Presentation] Antiviral effects and action mechanisms of novel N-(morpholine-4-carbonyloxy) amidine compaunds against hepatitis C virus.2012

    • Author(s)
      Kusano-Kitazume A, Sakamoto N, Azuma S, Asahina Y, Watanabe M et al
    • Organizer
      AASLD The Liver Meeting 2012
    • Place of Presentation
      Boston
    • Related Report
      2012 Annual Research Report
  • [Presentation] IL-6-mediated intersubgenotypic variation of interferon sensitivity in hepatitis C virus genotype 2a/2b chimeric clones2011

    • Author(s)
      Suda G, Sakamoto N, Itsui Y, Nakagawa M, Tasaka-Fujita M, Funaoka Y, Watanabe T, Nitta S, Kiyohashi K, Azuma S, Kakinuma S, Tsuchiya K, Imamura M, Hiraga N, Chayama K, Watanabe M
    • Organizer
      62th. Annual Meeting of American Association for the Study of Liver Diseases
    • Place of Presentation
      San Francisco
    • Year and Date
      2011-11-04
    • Related Report
      2012 Final Research Report 2011 Annual Research Report
  • [Presentation] ITPA gene variant protects against treatment-induced anemia and improves viral clearance by pegylated interferon-alfa and ribavirin therapy in chronic hepatitis C patients2011

    • Author(s)
      Sakamoto N, Azuma S, et al
    • Organizer
      62th. Annual Meeting of American Association for the Study of Liver Diseases
    • Place of Presentation
      San Francisco
    • Year and Date
      2011-11-04
    • Related Report
      2011 Annual Research Report
  • [Presentation] MMP-2 and MMP-14 derived from donor cells enhance therapeutic efficacy of liver cell transplantation in mice2011

    • Author(s)
      Kakinuma S, Sakamoto N, et al
    • Organizer
      62th. Annual Meeting of American Association for the Study of Liver Diseases
    • Place of Presentation
      San Francisco
    • Year and Date
      2011-11-04
    • Related Report
      2011 Annual Research Report
  • [Presentation] A high-content screening assay using infectious fluorescence-tagged hepatitis C virus reveals candidates for small molecule inhibitors of viral entry2011

    • Author(s)
      Kusano-Kitazume A, Sakamoto N, et al
    • Organizer
      62th. Annual Meeting of American Association for the Study of Liver Diseases
    • Place of Presentation
      San Francisco
    • Year and Date
      2011-11-04
    • Related Report
      2011 Annual Research Report
  • [Presentation] Loww of Wnt5A promotes biliary differentiation of murine hepatic stem/progenitor cells2011

    • Author(s)
      Kiyohashi K, Sakamoto N, et al
    • Organizer
      62th. Annual Meeting of American Association for the Study of Liver Diseases
    • Place of Presentation
      San Francisco
    • Year and Date
      2011-11-04
    • Related Report
      2011 Annual Research Report
  • [Presentation] Antiviral effect of a novel interferon-inducible protein, IFI-27, against hepatitis C virus replication2011

    • Author(s)
      Itsuil Y, Sakamoto N, et al
    • Organizer
      62th. Annual Meeting of American Association for the Study of Liver Diseases
    • Place of Presentation
      San Francisco
    • Year and Date
      2011-11-04
    • Related Report
      2011 Annual Research Report
  • [Presentation] Prediction model of ribavirin-induced anemia incorporating ITPA genotype could identify chronic hepatitis C patients at high risk of relapse among virological responders to pegylated-interferon and ribavirin2011

    • Author(s)
      Kurosaki M, Sakamoto N, et al
    • Organizer
      62th. Annual Meeting of American Association for the Study of Liver Diseases
    • Place of Presentation
      San Francisco
    • Year and Date
      2011-11-04
    • Related Report
      2011 Annual Research Report
  • [Presentation] IL28B and ITPA gene variants correlate with treatment efficacy in pegylated-interferon plus ribavirin therapy for chronic hepatitis C2011

    • Author(s)
      Matsuura K, Sakamoto N, et al
    • Organizer
      62th. Annual Meeting of American Association for the Study of Liver Diseases
    • Place of Presentation
      San Francisco
    • Year and Date
      2011-11-04
    • Related Report
      2011 Annual Research Report
  • [Presentation] Mutations in the interferon sensitivity determining region of HCV, age and total ribavirin dose is an independent predictor of relapse among early virological responders to peg-interferon plus ribavirin therapy2011

    • Author(s)
      Kurosaki M, Sakamoto N, et al
    • Organizer
      62th. Annual Meeting of American Association for the Study of Liver Diseases
    • Place of Presentation
      San Francisco
    • Year and Date
      2011-11-04
    • Related Report
      2011 Annual Research Report
  • [Presentation] HCV-NS4B targets STING and abrogates RIG-I-mediated type-I interferon-dependent innate immune response2011

    • Author(s)
      Nitta S, Sakamoto N, Nakagawa M, Kakinuma S, Mishima K, Kusano-KitazumeA, KiyohashiK, Murakawa M, Yoshino K, Tasaka-Fujita M, Watanabe M
    • Place of Presentation
      Seattle
    • Year and Date
      2011-09-08
    • Related Report
      2012 Final Research Report
  • [Presentation] Development of an RNA polymerase I-driven adenoviral vector and its application in an HCV replication assay2011

    • Author(s)
      Yoshida T, Sakamoto N, et al
    • Organizer
      18th. International Meeting on Hepatitis C Virus & Related Viruses
    • Place of Presentation
      Seattle
    • Year and Date
      2011-09-08
    • Related Report
      2011 Annual Research Report
  • [Presentation] Analysis of interferon signaling by infectious hepatitis C virus clones with substitutions of core amino acids 70 and 912011

    • Author(s)
      Sakamoto N, et al
    • Organizer
      18th. International Meeting on Hepatitis C Virus & Related Viruses
    • Place of Presentation
      Seattle
    • Year and Date
      2011-09-08
    • Related Report
      2011 Annual Research Report
  • [Presentation] HCV-NS4B targets STING and abrogates RIG-I-mediated type-I interferon-dependent innate immune response2011

    • Author(s)
      Nitta S, Sakamoto N, Tasaka-Fujita M, et al
    • Organizer
      18th. International Meeting on Hepatitis C Virus & Related Viruses
    • Place of Presentation
      Seattle
    • Year and Date
      2011-09-08
    • Related Report
      2011 Annual Research Report
  • [Presentation] HCV-NS4B蛋白とIFN発現シグナル分子との分子間相互作用の解析2011

    • Author(s)
      新田沙由梨、 坂本直哉、藤田めぐみ、北詰晶子、幾世橋佳、船岡祐介、渡辺貴子、植山真由美、小野塚泉、東正新、中川美奈、柿沼晴、渡辺守
    • Organizer
      第48回日本消化器免疫学会
    • Place of Presentation
      金沢
    • Year and Date
      2011-07-21
    • Related Report
      2012 Final Research Report
  • [Presentation] HCV-NS4B蛋白とRIG-I惹起性IFN産生シグナル関連蛋白との分子間相互作用の解析2011

    • Author(s)
      新田沙由梨、坂本直哉、藤田めぐみ、柿沼晴、村川美也子、北詰晶子、幾世橋佳、船岡祐介、渡辺貴子、植山真由美、小野塚泉、櫻井幸、中川美奈、東正新、渡辺守
    • Organizer
      第47回日本肝臓学会総会
    • Place of Presentation
      東京
    • Year and Date
      2011-06-02
    • Related Report
      2012 Final Research Report
  • [Presentation] Development of RNA pol-driven adenovirus vector expressing hepatitis C virus replicon2011

    • Author(s)
      Yamagishi Y, Sakamoto N, et al
    • Organizer
      Experimental Biology 2011
    • Place of Presentation
      Washington
    • Year and Date
      2011-04-13
    • Related Report
      2011 Annual Research Report
  • [Presentation] Antiviral effects of interferon-induced proteins GBP-1 and its interactions with hepatitis C virusNS5B protein2009

    • Author(s)
      Itsui Y, Sakamoto N, Nakagawa M, Osajima Y, Tasaka M, Sakurai Y, Suda G, Karakama Y, Mishima K, Yamamoto M, Watanabe T, Ueyama M, Funaoka Y, Azuma S (Chen CH), Kakinuma S, Yauchi T, Watanabe M
    • Organizer
      60th. Annual Meeting of American Association for the Study of Liver Diseases
    • Place of Presentation
      Boston
    • Year and Date
      2009-11-02
    • Related Report
      2012 Final Research Report
  • [Presentation] インターフェロン発現・作動機構とHCV蛋白2009

    • Author(s)
      田坂めぐみ
    • Organizer
      第13回日本肝臓学会大会
    • Place of Presentation
      京都
    • Year and Date
      2009-10-14
    • Related Report
      2012 Final Research Report
  • [Presentation] インターフェロン発現・作動機構とHCV蛋白2009

    • Author(s)
      藤田めぐみ
    • Organizer
      第13回 日本肝臓学会大会
    • Place of Presentation
      国立京都国際会館
    • Year and Date
      2009-10-14
    • Related Report
      2009 Annual Research Report
  • [Presentation] Establishment and genetic analyses of cytopathogenic HCV-JFH1 mutants by plaque-forming assay2009

    • Author(s)
      Mishima K, Sakamoto N, Sekine-Osajima Y, Nakagawa M, Tasaka M, Nishimura-Sakurai Y, Itsui Y, Wakita T, Watanabe M
    • Place of Presentation
      Nice
    • Year and Date
      2009-10-03
    • Related Report
      2012 Final Research Report
  • [Presentation] Genotype 2型C型慢性肝炎のインターフェ ロン治療再燃例に対する再治療の試み2009

    • Author(s)
      渡辺貴子、中川美奈、船岡祐介、植山真由美、三島果子、山本満千、小貫優子、須田剛生、櫻井幸、田坂めぐみ、筬島裕子、井津井康浩、陳正新、坂本直哉、渡辺守
    • Organizer
      第45回日本肝臓学会総会
    • Place of Presentation
      神戸
    • Year and Date
      2009-06-04
    • Related Report
      2012 Final Research Report
  • [Presentation] HCV増殖を制御するInterferon誘導蛋白とHCV非構造蛋白の相互作用の解析2009

    • Author(s)
      井津井康浩、 坂本直哉、中川美奈、筬島裕子、田坂めぐみ、櫻井幸、須田剛生、三島果子、山本満千、植山真由美、渡辺貴子、 船岡祐介、渡辺守
    • Organizer
      第45回日本肝臓学会総会
    • Place of Presentation
      神戸
    • Year and Date
      2009-06-04
    • Related Report
      2012 Final Research Report
  • [Presentation] 細胞障害性HCV-JFH1 subcloneの単離と機能解析2009

    • Author(s)
      三島果子、坂本直哉、中川美奈、井津井康浩、筬島裕子、田坂めぐみ、櫻井幸、須田剛生、山本満千、植山真由美、渡辺貴子、船岡祐介、渡辺守
    • Organizer
      第45回日本肝臓学会総会
    • Place of Presentation
      神戸
    • Year and Date
      2009-06-04
    • Related Report
      2012 Final Research Report
  • [Presentation] Genotype 2b急性肝炎由来HCVクローンの構築と増殖・粒子形成能の解析2009

    • Author(s)
      須田剛生、坂本直哉、中川美奈、田坂めぐみ、櫻井幸、小貫優子、山本満千、渡辺貴子、植山真由美、船岡祐介、井津井康浩、陳正新、今村道雄、茶山一彰、渡辺守
    • Organizer
      第45回日本肝臓学会総会
    • Place of Presentation
      神戸
    • Year and Date
      2009-06-04
    • Related Report
      2012 Final Research Report
  • [Presentation] HCVコア変異株培養系を用いたインターフェロン感受性、細胞内増殖、粒子分泌能の解析2009

    • Author(s)
      船岡祐介、坂本直哉、井津井康浩、須田剛生、中川美奈、田坂めぐみ、櫻井幸、小貫優子、山本満千、渡辺貴子、植山真由美、陳正新、渡辺守
    • Organizer
      第45回日本肝臓学会総会
    • Place of Presentation
      神戸
    • Year and Date
      2009-06-04
    • Related Report
      2012 Final Research Report
  • [Presentation] HCV複製増殖に関連する糖脂質代謝ネットワークの網羅的解析2009

    • Author(s)
      櫻井幸、坂本直哉、中川美奈、井津井康浩、田坂めぐみ、小貫優子、須田剛生、三島果子、山本満千、植山真由美、船岡祐介、渡辺貴子、陳正新、渡辺守
    • Organizer
      第45回日本肝臓学会総会
    • Year and Date
      2009-06-04
    • Related Report
      2012 Final Research Report
  • [Presentation] HCV genotype 1b 株キメラウイルスを用いたHCV core 領域アミノ酸 70/91 変異株の解析

    • Author(s)
      藤田めぐみ、脇田隆宇、加藤孝宣
    • Organizer
      第48回 日本肝臓学会総会
    • Place of Presentation
      ホテル日航金沢(石川)
    • Related Report
      2012 Annual Research Report
  • [Presentation] HCV-NS4B Protein Binds STING and Blocks the RIG-I Mediated IFN Pathway.

    • Author(s)
      Nitta S, Sakamoto N, Tasaka-Fujita M, Asahina Y, Watanabe M et al
    • Organizer
      The 10th JSH Single Topic Conference
    • Place of Presentation
      Tokyo
    • Related Report
      2012 Annual Research Report
  • [Presentation] Association of Gene Expression Involving Innate Immunity and IFN Signaling with Genetic Variation in IL28B in Patients with Chronic Hepatitis C.

    • Author(s)
      Asahina Y, Murakawa M, Watanabe M et al
    • Organizer
      The 10th JSH Single Topic Conference
    • Place of Presentation
      Tokyo
    • Related Report
      2012 Annual Research Report
    • Invited
  • [Presentation] Discovery of N-(morpholine-4-carbonyloxy) amidine compounds as potent inhibitors against hepatitis C virus replication.

    • Author(s)
      Kusano-Kitazume A, Sakamoto N, Asahina Y, Watanabe M et al
    • Organizer
      The 10th JSH Single Topic Conference
    • Place of Presentation
      Tokyo
    • Related Report
      2012 Annual Research Report
  • [Presentation] Impaired induction of IL28B expression in PBMC is associated with null response to interferon therapy in chronic hepatitis C.

    • Author(s)
      Murakawa M, Sakamoto N, Asahina Y, Watanabe M et al
    • Organizer
      19th International Symposium on Hepatitis C Virus and Related Viruses
    • Place of Presentation
      Venice
    • Related Report
      2012 Annual Research Report
  • [Presentation] HCV-NS4B blocks the RIG-I mediated IFN pathway through targeting of STING.

    • Author(s)
      Nitta S, Sakamoto N, Tasaka-Fujita M, Asahina Y, Watanabe M et al
    • Organizer
      19th International Symposium on Hepatitis C Virus and Related Viruses
    • Place of Presentation
      Venice
    • Related Report
      2012 Annual Research Report
  • [Book] 肝癌治療実践のKnack & Pitfalls RFAのoutcome診療ガイドラインに沿った肝癌治療の要点と盲点2013

    • Author(s)
      高山忠利、泉並木、朝比奈靖浩
    • Publisher
      文光堂
    • Related Report
      2012 Annual Research Report
  • [Book] 肝臓病診療 ゴールデンハンドブック 改訂第2版2013

    • Author(s)
      泉並木、朝比奈靖浩
    • Publisher
      南江堂
    • Related Report
      2012 Annual Research Report
  • [Book] 肝炎ウイルスーB型・C型2012

    • Author(s)
      熊田博光、朝比奈靖浩
    • Publisher
      医薬ジャーナル社
    • Related Report
      2012 Annual Research Report
  • [Book] 臨床検査のガイドライン2012

    • Author(s)
      日本臨床検査医学会ガイドライン作成委員会、朝比奈靖浩
    • Publisher
      株式会社宇宙堂八木書店
    • Related Report
      2012 Annual Research Report
  • [Patent(Industrial Property Rights)] C型肝炎ウイルスの増殖を抑制する医薬組成物2011

    • Inventor(s)
      坂本直哉、渡辺守、北詰晶子、萩原正敏、奥野友紀子
    • Industrial Property Rights Holder
      東京医科歯科大学
    • Industrial Property Number
      2011-194082
    • Filing Date
      2011-09-06
    • Related Report
      2011 Annual Research Report

URL: 

Published: 2009-04-01   Modified: 2019-07-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi